IFNIKB: a type I interferon database for antitumour immunity studies
Database · 2026
DOI: 10.1093/database/baag053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Database, 2026. Verfasst von Fubo Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Computer Science, Sichuan University, Chengdu, 610065, China. Hauptthemen laut MEDLINE: Interferon Type I, Databases, Protein. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Science and Technology Major Project, Sichuan Science and Technology Program key project.
Abstract (Originalsprache)
Type I interferon (IFN-I) is an important class of cytokines that can inhibit tumour progression through mechanisms such as immunomodulation of the tumour microenvironment or targeting cellular components. Although various endogenous and exogenous IFN-I therapeutic strategies have been developed, reports of immune cell dysfunction resulting from IFN-I signal enhancement indicate that optimal strategies have yet to be established. However, heterogeneous data of IFN-I are currently spread across multiple public databases and lack systematic integration, which poses challenges for knowledge acquisition and clinical research promotion. Herein, we develop the IFN-I Knowledge Base (IFNIKB), the first specific database for IFN-I. It integrates 26 273 literature articles on IFN-I antitumour immunity, 2202 clinical trial records, and data on 8372 genes and 7164 proteins across 654 species. Furthermore, we design an automated workflow for knowledge discovery from literature. Users can construct on-demand knowledge graphs to explore entities and relationships through interactive visualizations, temporal trends, and network topology analyses. Additionally, we provide tools for multiple sequence alignment, sequence identity computation, and phylogenetic analysis to interpret IFN-I from molecular perspectives. Therefore, researchers can employ IFNIKB to conveniently acquire knowledge, propose hypothesis, optimize experimental design, and identify potential clinical therapeutic targets. Database URL: http://www.combio-lezhang.online/IFNIKB/home
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Computer Science, Sichuan University, Chengdu, 610065, China.
- West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
- Key Laboratory of Biomacromolecules (CAS), National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
ORCID-Profile: Le Zhang
Förderung
- National Natural Science Foundation of China
- National Science and Technology Major Project
- Sichuan Science and Technology Program key project
Zitieren
APA
Ma, F., Li, K., Yu, Y., Zhang, L., Zhang, L., Li, B., & Zhang, L. (2026). IFNIKB: a type I interferon database for antitumour immunity studies. Database. https://doi.org/10.1093/database/baag053
Vancouver
Ma F, Li K, Yu Y, Zhang L, Zhang L, Li B, et al. IFNIKB: a type I interferon database for antitumour immunity studies. Database. 2026. doi:10.1093/database/baag053
BibTeX
@article{Ma2026,
author = {Ma, Fubo and Li, Kang and Yu, Yangchao and Zhang, Lei and Zhang, Liguo and Li, Bing and Zhang, Le},
title = {IFNIKB: a type I interferon database for antitumour immunity studies},
journal = {Database},
year = {2026},
doi = {10.1093/database/baag053}
}
EUVIMED